Total Payments
$1,448
2024 Payments
$75.10
Companies
20
Transactions
76
Medicare Patients
1,940
Medicare Billing
$613,515
Payment Breakdown by Category
Food & Beverage$1,177 (81.2%)
Other$200.00 (13.8%)
Education$71.63 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,177 | 70 | 81.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 13.8% |
| Education | $71.63 | 5 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $330.49 | 21 | $0 (2024) |
| Vifor Pharma, Inc. | $212.14 | 2 | $0 (2022) |
| Genentech USA, Inc. | $187.03 | 15 | $0 (2019) |
| Relypsa, Inc. | $183.03 | 9 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $131.09 | 8 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $77.56 | 4 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $49.05 | 3 | $0 (2019) |
| GENZYME CORPORATION | $40.80 | 2 | $0 (2022) |
| Amicus Therapeutics, Inc. | $28.15 | 1 | $0 (2020) |
| NxStage Medical, Inc. | $26.92 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.10 | 4 | GlaxoSmithKline, LLC. ($31.17) |
| 2023 | $271.36 | 17 | GlaxoSmithKline, LLC. ($229.41) |
| 2022 | $145.88 | 8 | OPKO Pharmaceuticals, LLC ($40.13) |
| 2021 | $251.03 | 4 | Vifor Pharma, Inc. ($200.00) |
| 2020 | $123.91 | 6 | Relypsa, Inc. ($43.97) |
| 2019 | $133.34 | 7 | Otsuka America Pharmaceutical, Inc. ($43.32) |
| 2018 | $253.11 | 15 | Genentech USA, Inc. ($68.05) |
| 2017 | $194.62 | 15 | Genentech USA, Inc. ($106.47) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEPHROLOGY | ||||||
| 02/02/2024 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: NEPHROLOGY | ||||||
| 01/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/19/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEPHROLOGY | ||||||
| 12/06/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Genetic Disease | ||||||
| 11/10/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEPHROLOGY | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: NEPHROLOGY | ||||||
| 10/20/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: NEPHROLOGY | ||||||
| 10/04/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.05 | General |
| Category: NEPHROLOGY | ||||||
| 09/01/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: IMMUNOLOGY | ||||||
| 01/10/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Genetic Disease | ||||||
| 10/19/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.73 | General |
| Category: NEPHROLOGY | ||||||
| 09/12/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 420 | 919 | $551,358 | $130,411 |
| 2022 | 12 | 402 | 1,112 | $572,967 | $140,045 |
| 2021 | 13 | 501 | 1,321 | $700,490 | $181,235 |
| 2020 | 14 | 617 | 1,658 | $732,216 | $161,824 |
Total Patients
1,940
Total Services
5,010
Medicare Billing
$613,515
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 49 | 343 | $371,469 | $89,192 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 165 | $33,621 | $9,511 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 75 | $16,575 | $6,602 | 39.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 61 | 105 | $43,471 | $5,388 | 12.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $18,182 | $4,539 | 25.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 43 | $17,239 | $4,070 | 23.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 17 | $15,266 | $3,073 | 20.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 32 | $9,804 | $2,671 | 27.2% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 15 | 35 | $14,022 | $2,239 | 16.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 43 | $6,339 | $1,580 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $1,807 | $812.16 | 44.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $3,564 | $734.52 | 20.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 52 | 385 | $404,635 | $101,663 | 25.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 140 | $28,319 | $7,481 | 26.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 58 | 117 | $47,755 | $6,420 | 13.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 27 | $23,544 | $6,084 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 53 | $11,713 | $4,437 | 37.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $13,960 | $3,707 | 26.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 28 | $11,286 | $2,645 | 23.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 31 | $9,686 | $2,307 | 23.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 56 | $8,310 | $1,579 | 19.0% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 15 | 214 | $7,276 | $1,565 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 21 | $2,919 | $1,304 | 44.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 12 | $3,564 | $852.29 | 23.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 85 | 514 | $524,280 | $137,373 | 26.2% |
About Dr. Osaid Ahmad, MD
Dr. Osaid Ahmad, MD is a Nephrology healthcare provider based in Neenah, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689618589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Osaid Ahmad, MD has received a total of $1,448 in payments from pharmaceutical and medical device companies, with $75.10 received in 2024. These payments were reported across 76 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,177).
As a Medicare-enrolled provider, Ahmad has provided services to 1,940 Medicare beneficiaries, totaling 5,010 services with total Medicare billing of $613,515. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Neenah, WI
- Active Since 06/15/2006
- Last Updated 02/10/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1689618589
Products in Payments
- Veltassa (Drug) $383.03
- BENLYSTA (Biological) $247.16
- Rituxan (Biological) $187.03
- JESDUVROQ (Drug) $83.33
- JYNARQUE (Drug) $77.56
- Rayaldee (Drug) $58.32
- RAYALDEE (Drug) $58.18
- ACTHAR (Biological) $49.05
- GALAFOLD (Drug) $28.15
- System One (Device) $26.92
- Parsabiv (Biological) $26.59
- JARDIANCE (Drug) $25.08
- ONPATTRO (Drug) $23.90
- FABRAZYME (Biological) $22.49
- Auryxia (Drug) $21.63
- Velphoro (Drug) $18.85
- FABRY-DISEASE (Drug) $18.31
- KRYSTEXXA (Drug) $16.57
- Rayaldee (old) (Drug) $14.59
- LUPKYNIS (Drug) $11.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.